Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
The Journal of Clinical Investigation
|
August 29, 2017
Genome editing of human embryos: to edit or not to edit, that is the question
Srinivasan Chandrasegaran, C Korin Bullen, Dana Carroll
Journal of Infectious Disease and Therapy
|
May 15, 2024
Mycobacterial Nucleic Acids Modulate Host Innate Immune Responses
Geetha Srikrishna, C Korin Bullen, William R Bishai
Methods in Molecular Biology (Clifton, N.J.)
|
May 13, 2022
Quantification of Infectious SARS-CoV-2 by the 50% Tissue Culture Infectious Dose Endpoint Dilution Assay
C Korin Bullen, Stephanie L Davis, Monika M Looney
Nature Medicine
|
March 25, 2014
New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
C Korin Bullen, Gregory M Laird, Christine M Durand, et al.
JCI Insight
|
September 19, 2023
MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival
C Korin Bullen, Alok K Singh, Stefanie Krug, et al.
Nature Protocols
|
November 7, 2014
A primary CD4(+) T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence
Michelle Kim, Nina N Hosmane, C Korin Bullen, et al.
Journal of Proteome Research
|
May 15, 2020
Relative and Quantitative Phosphoproteome Analysis of Macrophages in Response to Infection by Virulent and Avirulent <i>Mycobacteria</i> Reveals a Distinct Role of the Cytosolic RNA Sensor RIG-I in <i>Mycobacterium tuberculosis</i> Pathogenesis
Eira Choudhary, C Korin Bullen, Renu Goel, et al.
The Yale Journal of Biology and Medicine
|
June 29, 2017
Characterization of Elite Suppressors Cell-Associated HIV-1 mRNA at Baseline and with T Cell Activation
Christopher W Pohlmyer, C Korin Bullen, Alyssa R Martin, et al.
The Journal of Clinical Investigation
|
March 31, 2015
Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations
Gregory M Laird, C Korin Bullen, Daniel I S Rosenbloom, et al.
Antiviral Research
|
February 5, 2023
Nucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells
Vanessa F Merino, Yu Yan, Alvaro A Ordonez, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
The Journal of Clinical Investigation
|
August 29, 2017
Genome editing of human embryos: to edit or not to edit, that is the question
Srinivasan Chandrasegaran, C Korin Bullen, Dana Carroll
Journal of Infectious Disease and Therapy
|
May 15, 2024
Mycobacterial Nucleic Acids Modulate Host Innate Immune Responses
Geetha Srikrishna, C Korin Bullen, William R Bishai
Methods in Molecular Biology (Clifton, N.J.)
|
May 13, 2022
Quantification of Infectious SARS-CoV-2 by the 50% Tissue Culture Infectious Dose Endpoint Dilution Assay
C Korin Bullen, Stephanie L Davis, Monika M Looney
Nature Medicine
|
March 25, 2014
New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
C Korin Bullen, Gregory M Laird, Christine M Durand, et al.
JCI Insight
|
September 19, 2023
MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival
C Korin Bullen, Alok K Singh, Stefanie Krug, et al.
Nature Protocols
|
November 7, 2014
A primary CD4(+) T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence
Michelle Kim, Nina N Hosmane, C Korin Bullen, et al.
Journal of Proteome Research
|
May 15, 2020
Relative and Quantitative Phosphoproteome Analysis of Macrophages in Response to Infection by Virulent and Avirulent <i>Mycobacteria</i> Reveals a Distinct Role of the Cytosolic RNA Sensor RIG-I in <i>Mycobacterium tuberculosis</i> Pathogenesis
Eira Choudhary, C Korin Bullen, Renu Goel, et al.
The Yale Journal of Biology and Medicine
|
June 29, 2017
Characterization of Elite Suppressors Cell-Associated HIV-1 mRNA at Baseline and with T Cell Activation
Christopher W Pohlmyer, C Korin Bullen, Alyssa R Martin, et al.
The Journal of Clinical Investigation
|
March 31, 2015
Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations
Gregory M Laird, C Korin Bullen, Daniel I S Rosenbloom, et al.
Antiviral Research
|
February 5, 2023
Nucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells
Vanessa F Merino, Yu Yan, Alvaro A Ordonez, et al.
Page
of 2